Classes
Publications
- Lipid-lowering in diabetes: An update2023 | First Faculty of Medicine
- PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated? Czech atherosclerosis society statement2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Monoclonal antibodies in the treatment of dyslipidemia and cardiovascular risk lowering2016 | First Faculty of Medicine
- A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy2015 | First Faculty of Medicine
- Plant sterols and stanols: not yet own recommendations for diet enrichment targeted reduction of LDL - cholesterol and cardiovascular risk2015 | First Faculty of Medicine
- Interaction of common sequence variants and selected risk factors in determination of HDL cholesterol levels.2010 | First Faculty of Medicine
- Hyperlipoproteinaemia and dyslipoproteinaemia 1. Classification, diagnostics, cardiovascular, cardiometabolic, residual risk2010 | First Faculty of Medicine
- Fibrates in the treatment of diabetic dyslipidemia2010 | First Faculty of Medicine
- Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study2024 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine
Loading network view...